Cosmetic Surgery Products


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Cosmetic Surgery Products

  1. 1. N EW Industry Studies ■ Custom Research ■ Focus Reports INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS US industry forecasts for 2012 & 2017 Cosmetic Surgery Products Study # 2389 September 2008 $4600 Visit our NEW and IMPROVED website at Demand to grow more than 8% annually through 2012 Demand for cosmetic surgery products in the US is forecast to increase 8.1 percent per year to $2.5 billion in 2012, based on increases in cosmetic surgery procedures, which are forecast to reach 16 million over the same time period. America’s obsession with a youthful appearance is longstanding, and is unlikely to subside anytime soon. This coupled with an aging population, a greater societal acceptance of cosmetic surgery, and an increasingly competitive work force will bode well for the cosmetic surgery industry. Due to much more busy lifestyles, less invasive cosmetic surgery procedures and products (such as injections, laser dermal resurfac- ing and microdermabrasion) that result in little or no recovery time will experience the best opportunities. However, demand for surgical products will continue to be strong in some areas, such as implants, where there are no notable alternatives. Lasers, microdermabrasion machines will offer steady equipment gains Equipment was the largest product type in 2007, with one-third of the market. Demand will be driven as a wider variety of practitioners are expected to increas- ingly offer cosmetic options as these procedures are generally “out-of-pocket” expenses and thus avoid the need to deal with insurance companies. The develop- ment of easier-to-use and safer equipment will also continue to open up strong opportunities in other end-users such as beauty salons and spas. Among equip- ment types, microdermabrasion machines and laser and other light-based systems will continue to achieve steady growth. Injectables, implants hold best growth prospects Implants and injectables will register the fastest growth over the forecast period. Implants will benefit from the return of silicone-filled implants in late 2006, after a 14 year hiatus from the mass market. Despite their higher cost, silicone-filled implants are often preferred over their saline counterparts due their more natural look and feel. In addition, the approval of so-called fifth generation silicone im- plants will also increase their use, as this type is less likely to leak or rupture in the body due to its more solid consistency. Growth in the injectables sector boomed with the introduction of BOTOX (Aller- gan) in the 1990s when it was used for “off label” wrinkle treatments. Further growth was achieved with the subsequent introduction of hyaluronic acid inject- ables. Growth in injectables will benefit from the ability of these products to provide a quick, non-invasive reduction in wrinkles with no required recovery time. Continued market penetration of newer fillers, such as polymethylmethac- rylate microspheres and poly-L lactic acid, will also provide opportunities. Study coverage Cosmetic Surgery Products is a new Freedonia industry study priced at $4600. It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 in current dollars by raw material, product, and procedure. This study also assesses market environment factors, details market share and profiles 28 US industry competitors. Copyright 2008 The Freedonia Group, Inc. US Cosmetic Surgery Product Demand ($1.7 billion, 2007) Equipment 33% Wound Care & Other 9% Implants 25% Injectables 33%
  2. 2. 8 Nonsurgical Cosmetic Procedures Demand by Type Cht Nonsurgical Cosmetic Procedures Demand by Type, 1997-2017 9 Cosmetic Injection Demand by Type 10 Botulinum Toxin Injection Demand 11 Soft Tissue Injection Demand by Type Cht Soft Tissue Injection Demand by Type, 1997-2017 12 Other Injection Demand 13 Laser Treatment Demand by Type 14 Dermal Resurfacing Treatments Demand by Type 15 Other Nonsurgical Cosmetic Treatment Demand PRODUCTS General Equipment Lasers Hair Removal Dermal Resurfacing Other Microdermabrators Consumables Liposuction Equipment Other Injectables Botulinum Toxin Tissue Fillers Hyaluronic Acid Collagen Other Calcium Hydroxylapatite All Others Other Implants Breast Implants Types of Breast Implants Producers Other Implants Lip Chin & Cheek All Other Wound Care Disposables Bandages & Dressings Wound Closures Other Other Cosmetic Surgery Products LIST OF TABLES & CHARTS: 1 Cosmetic Surgery Products Demand by Type Cht Cosmetic Surgery Products Demand by Type, 1997-2017 2 Cosmetic Surgery Equipment Demand by Type 3 Cosmetic Laser Demand by Type 4 Microdermabrator Demand 5 Cosmetic Surgery Consumables Demand 6 Liposuction Equipment Demand Executive Summary 1 Summary Table Market Environment General Demographic Trends Macroeconomic Outlook Consumer Spending Outlook Medical Provider & Facility Trends Spa Industry Outlook Competitive Product Trends Medical Product Market Outlook Regulatory Issues LIST OF TABLES & CHARTS: 1 Population & Households 2 Macroeconomic Indicators 3 Personal Consumption Expenditures 4 Medical Providers & Facilities 5 Spa Facilities by Type 6 Selected Medical Product Demand by Type COSMETIC PROCEDURES General Surgical Reshaping Lifts & Tucks Implants Liposuction Other Nonsurgical Injections Botulinum Toxin Soft Tissue Fillers Hyaluronic Acid Collagen Fat Other Soft Tissue Fillers Other Injections Laser Treatments Laser Dermal Resurfacing Hair Removal Other Laser Treatments Dermal Resurfacing Other LIST OF TABLES & CHARTS: 1 Cosmetic Procedures Demand by Type Cht Cosmetic Procedures Demand by Type, 1997-2017 2 Surgical Cosmetic Procedures Demand by Type Cht Surgical Cosmetic Procedures Demand by Type, 2007 3 Cosmetic Reshaping Procedures Demand by Type 4 Cosmetic Lift & Tuck Demand by Type 5 Cosmetic Implant Procedures Demand by Type 6 Liposuction Procedures Demand 7 Other Surgical Cosmetic Procedures Demand 7 Other Cosmetic Surgery Equipment Demand 8 Cosmetic Surgery Injectables Demand 9 Botulinum Toxin Demand in Cosmetic Surgery 10 Tissue Fillers Demand in Cosmetic Surgery 11 Hyaluronic Acid Fillers Demand in Cosmetic Surgery 12 Collagen Fillers Demand in Cosmetic Surgery 13 Other Tissue Fillers Demand in Cosmetic Surgery 14 Other Injectables Demand in Cosmetic Surgery 15 Cosmetic Surgery Implants Demand 16 Breast Implants Demand 17 Other Cosmetic Implants Demand by Type 18 Cosmetic Surgery Wound Care Disposables Demand 19 Bandages & Dressings Demand in Cosmetic Surgery 20 Wound Closures Demand in Cosmetic Surgery 21 Other Wound Care Disposables Demand in Cosmetic Surgery 22 Other Cosmetic Surgery Products Demand RAW MATERIALS General Biological Materials Microbial Extracts Collagen Other Polymers Other LIST OF TABLES & CHARTS: 1 Cosmetic Surgery Raw Material Demand 2 Biological Materials Demand in Cosmetic Surgery Products 3 Polymers Demand in Cosmetic Surgery Products 4 Other Raw Material Demand in Cosmetic Surgery Products INDUSTRY STRUCTURE General Market Share Industry Restructuring Competitive Strategies Research & Development Cooperative Agreements Marketing LIST OF TABLES & CHARTS: 1 US Cosmetic Surgery Product Sales by Company, 2007 Cht US Cosmetic Surgery Product Market Share by Company, 2007 2 Selected Acquisitions & Divestitures 3 Selected Cooperative Agreements Company Profiles NEW US Industry Study with Forecasts for 2012 & 2017 Cosmetic Surgery Products Contents/Tables/Charts historical data (1997, 2002, 2007) plus forecasts for 2012 and 2017
  3. 3. INDUSTRY MARKET RESEARCH: BUSINESS INTELLIGENCE FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS Industry Studies ■ Custom Research ■ Focus Reports Products Breast Implants Based on the continued market penetration of higher-priced silicone-filled varieties (after a 14 year hiatus, courtesy of the US FDA) and ongoing societal trends encouraging appearance-enhancing cosmetic surgery, demand for breast implants will increase eleven percent annually to $680 million in 2012. A decrease in the number of mastectomies and reconstructive breast procedures will moderate even faster gains. These decreases will result from improving breast cancer therapies and changing approaches to breast cancer treatment. By contrast, the number of breast augmentation surgeries is expected to rise due to the availability of better implants and the development of less invasive and less costly implantation techniques. In total, the number of breast implant procedures in the US is projected to reach 540,000 in 2012, up from 380,000 in 2007. In 2007, more than one-third of breast implant recipients chose silicone gel-filled implants over the saline-filled alternative. Many women believe that the former has a more natural look and feel, which will likely lead to a continued shift toward the silicone type going forward. In addition, the approval of so- called fifth generation silicone implants will also increase their use, as this type is less likely to leak or rupture in the body due to its more solid consistency. While the gel in the third and fourth generation types have a jellylike consis- tency, that in the fifth generation type can be compared to “gummy bear” candy. An example of the fifth generation type is Mentor’s silicone gel-filled breast implants filled with the company’s patented MEMORYGEL cohesive silicone gel that is formulated to provide a texture similar to that of normal breast tissue. During breast enlargement surgery (augmentation mammoplasty), an implant is placed under the breast tissue or under the chest muscle beneath the breast. To position the implant, an incision is made in the bottom crease of the breast, the armpit, or along the lower edge of the areola. The implant is inserted through the incision, adjusted to the correct shape and position, and closed with stitches. ©Copyright by The Freedonia Group, Inc. SAMPLE PAGE Explanations that support each table’s data and forecasts cosmetic procedures Hyaluronic Acid -- Demand for hyaluronic acid injections is forecast to increase 7.6 percent per year to 1.8 million injections, valued at $1.0 billion in 2012. Hyaluronic acid will continue to penetrate the injection market, primarily due to favorable performance characteristics and greater availability. A por- tion of growth for hyaluronic acid injections will come at the expense of other tissue fillers, particularly collagen and fat, due to ease of use and performance advantages. As such, hyaluronic acid will account for over three-quarters of total number of soft tissue filler injections in 2012, up from 70 percent in 2007. In December 2003, the first hyaluronic acid product, RESTYLANE (made by Sweden’s Q-Med and sold in the US by Medicis), was approved by the FDA for cosmetic applications. Hyaluronic acid is a natural substance found in the ©Copyright by The Freedonia Group, Inc. TABLE III-11 SOFT TISSUE INJECTION DEMAND BY TYPE Item 1997 2002 2007 2012 2017 Resident Population (mil persons) 273 288 302 315 329 injections/000 capita 1.2 1.5 5.9 7.6 9.6 Soft Tissue Filler Injections (000) 315 435 1765 2400 3160 Hyaluronic Acid -- -- 1250 1800 2450 Collagen 275 360 250 240 230 Fat 40 75 50 45 40 Other Soft Tissue Fillers neg neg 215 315 440 $/procedure 430 515 630 670 715 Soft Tissue Filler Injections (mil $) 135 225 1110 1610 2260 Hyaluronic Acid -- -- 730 1115 1620 Collagen 95 150 120 125 130 Fat 40 75 75 75 70 Other Soft Tissue Fillers neg neg 185 295 440 SAMPLE TABLE Historical data for 1997, 2002 and 2007 as well as Freedonia forecasts for 2012 and 2017 COMPANY PROFILES Profiles for 33 competitors in the US industry such as Allergan, Medicis Pharma- ceutical and Mentor SAMPLE TEXT Data illustrated with the aid of nearly 60 tables and charts • Establishing consistent economic and market forecasts • Using input/output ratios, flow charts and other economic methods to quantify data • Employing in-house analysts who meet stringent quality standards • Interviewing key industry participants, experts and end users • Researching a proprietary database that includes trade publications, government reports and corporate literature Freedonia’s methods involve: This study can help you: • Determine your market & sales potential • Learn more about industry competitors • Assess new products & technologies • Identify firms to merge with or acquire • Complement your research & planning • Gather data for presentations • Confirm your own internal data • Make better business decisions
  4. 4. Click here to purchase online Need analysis on a topic not covered by Freedonia Industry Studies? Call Customer Service for details on Freedonia Custom Research Other Titles from The Freedonia Group Order Information To order fill out the coupon below and mail to The Freedonia Group, or place your order by phone toll free (800) 927-5900 (US) or (440) 684-9600, or by fax (440) 646-0484, or by e-mail at Free Handling and Shipping There is NO charge for handling and UPS shipping in the US. Expect delivery in 3 to 5 days. Outside the US, Freedonia provides free airmail service. If you require express delivery, Freedonia provides this to you at cost. Save Fifteen Percent If you order three (3) different titles at the same time, you can receive a discount of 15%. If your order is accompanied by a check, you may take a 5% cash discount (discounts do not apply to corporate use licenses). Credit Card Orders You may charge your order to either American Express, MasterCard or Visa. Please include your credit card account number, expiration date and your signature. Orders Outside of the US Checks must be paid in US funds, drawn against a US bank and mailed directly to The Freedonia Group. For wire transfer instructions please contact our cus- tomer service department at info@freedoniagroup. com. Or you may use a credit card. Corporate Use License Now every decision maker in your organization can act on the key intelligence found in all Freedonia studies. For an additional $2,300 you receive unlimited use of an electronic version (PDF) of the study. Place it on your Intranet, e-mail it to coworkers around the world, or print it as many times as you like! Order it today. Online Access The complete text and tables from our studies and reports can be purchased at our website and through major commercial online hosts. Name: Company: Division: Street: City/State/Zip: Country: (no PO Box please) Phone: Fax: Title: Total (including selected options): $ Signature: Credit Card # Expiration Date yearmonth e-mail: PRICEORDER FORM TITLE The Freedonia Group, Inc. 767 Beta Drive Cleveland, OH 44143-2326 USA website: phone: 800-927-5900 (US) or 440-684-9600 fax: 440-646-0484 e-mail: Bill my company American Express MasterCard Visa Enclosed is my check (5% discount) drawn on a US bank and payable to The Freedonia Group, Inc., in US funds (Ohio residents add 7.75% sales tax) Cosmetic Surgery Products $4600 Corporate Use License (add to study price) + $2300 __ Additional Print Copies @ $500 each INQ-2389 Implantable Medical Devices US medical implant demand will rise 9.3% yearly through 2011. Cardiac implants will remain the top-selling group, led by stents and defibrillators. Bone cement, tissue and spinal implants will pace gains in the orthopedic segment. Other fast-growing types include neu- rological stimulators, cochlear devices and gas- tric bands. This study analyzes the $27.9 billion US medical implant industry, with forecasts for 2011 and 2016 by material and product. It also evaluates market share and profiles major players. #2255............................10/2007................................$4500 Drug Delivery Systems US demand for drug delivery systems will grow 10% annually through 2012. Oral types will remain the largest drug delivery category while parenteral, inhalation and implantable systems grow the fastest. Parenteral formulations will eventually surpass oral dosages as the largest product group. This study analyzes the $80.2 billion US drug delivery system industry, with forecasts for 2012 and 2017 by material, type and application. It also evaluates company market share and profiles leading industry players. #2294...........................03/2008................................$4500 Orthopedic Implants US orthopedic implant demand will grow 8.9% annually through 2012. Knees and hips will continue to claim most reconstructive joint replacements. New technologies and surgi- cal techniques will boost demand for spinal implants. Orthobiologics will benefit from break- throughs in biotechnology and nanotechnol- ogy. This study analyzes the $14.3 billion US orthopedic implant industry, with forecasts for 2012 and 2017 by product and market. It also evaluates company market share and profiles industry players. #2372............................07/2008................................$4500 Cardiac Implants The US cardiac implant industry is analyzed in this study. It presents historical demand data (1997, 2002, 2007) and forecasts for 2012 and 2017 by type (e.g., defibrillators, pacemakers, drug-eluting and other coronary stents, heart valves, vascular and related grafts, vena cava filters, ventricular-assist devices, implantable heart monitors), and market (e.g., hospitals, outpatient facilities, physicians' offices). The study also considers market environment factors, evaluates company market share and profiles industry competitors. #2398...........................09/2008................................$4500 Medical & Dental Adhesives & Sealants US demand for medical and dental adhesives and sealants will rise 7.6% annually through 2011, driven by continuing new product development and increasing acceptance in surgical and consumer settings. Opportunities are expected for cyanoacrylate, polyethylene glycol and various plasma and protein types. This study analyzes the US market for medical adhesives and sealants, with forecasts for 2011 and 2016 presented by product and market. It also evaluates company market share and profiles major suppliers. #2201...........................05/2007................................$4400